Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

533 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort.
Mihai C, Distler O, Gheorghiu AM, Constantin PI, Dobrota R, Jordan S, Smith V, Hachulla E, Henes J, Siegert E, Vettori S, Müller-Ladner U, Matucci Cerinic M, Allanore Y; EUSTAR collaborators. Mihai C, et al. Among authors: allanore y. Rheumatology (Oxford). 2020 Aug 1;59(8):2016-2023. doi: 10.1093/rheumatology/kez558. Rheumatology (Oxford). 2020. PMID: 31790136
Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients.
Allanore Y, Borderie D, Airo P, Guiducci S, Czirják L, Nasonov EL, Riemekasten G, Caramaschi P, Majdan M, Krasowska D, Friedl E, Lemarechal H, Ananieva LP, Nievskaya T, Ekindjian OG, Matucci-Cerinic M, Kahan A. Allanore Y, et al. Ann Rheum Dis. 2007 Feb;66(2):257-9. doi: 10.1136/ard.2006.054346. Epub 2006 Jun 1. Ann Rheum Dis. 2007. PMID: 16740682 Free PMC article.
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.
Bérezné A, Ranque B, Valeyre D, Brauner M, Allanore Y, Launay D, Le Guern V, Kahn JE, Couderc LJ, Constans J, Cohen P, Mahr A, Pagnoux C, Hachulla E, Kahan A, Cabane J, Guillevin L, Mouthon L. Bérezné A, et al. Among authors: allanore y. J Rheumatol. 2008 Jun;35(6):1064-72. Epub 2008 May 1. J Rheumatol. 2008. PMID: 18464307
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells.
Distler JH, Allanore Y, Avouac J, Giacomelli R, Guiducci S, Moritz F, Akhmetshina A, Walker UA, Gabrielli A, Müller-Ladner U, Tyndall A, Matucci-Cerinic M, Distler O; EULAR Scleroderma Trials and Research group. Distler JH, et al. Among authors: allanore y. Ann Rheum Dis. 2009 Feb;68(2):163-8. doi: 10.1136/ard.2008.091918. Epub 2008 Jul 23. Ann Rheum Dis. 2009. PMID: 18653485 Free article.
A descriptive and prognostic study of systemic sclerosis-associated myopathies.
Ranque B, Authier FJ, Le-Guern V, Pagnoux C, Berezne A, Allanore Y, Launay D, Hachulla E, Kahan A, Cabane J, Gherardi R, Guillevin L, Mouthon L. Ranque B, et al. Among authors: allanore y. Ann Rheum Dis. 2009 Sep;68(9):1474-7. doi: 10.1136/ard.2008.095919. Epub 2008 Dec 3. Ann Rheum Dis. 2009. PMID: 19054827
533 results